Membrane traffic and turnover in TRP-ML1-deficient cells: A revised model for mucolipidosis type IV pathogenesis

Journal of Experimental Medicine

Volumn 205, Issue 6, 2008, Pages 1477-1490

  Miedel, Mark T ^a   Rbaibi, Youssef ^b   Guerriero, Christopher J ^a   Colletti, Grace ^b   Weixe, Kelly M ^a   Weisz, Ora A ^a   Kiselyov, Kirill ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN; SMALL INTERFERING RNA; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL MUCOLIPIN 1;

ARTICLE; BIOGENESIS; CELL STRUCTURE; CONTROLLED STUDY; DEGRADATION; ENDOCYTOSIS; ENDOSOME; FIBROBLAST; GENE MUTATION; HELA CELL; HUMAN; HYDROLYSIS; KINETICS; LYSOSOME; MUCOLIPIDOSIS; MUCOLIPIDOSIS TYPE 4; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ACYLTRANSFERASES; CELL MEMBRANE; ENDOCYTOSIS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; LIPIDS; LYSOSOMES; MODELS, BIOLOGICAL; MUCOLIPIDOSES; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 45149103982     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20072194     Document Type: Article

References (54)

1. Bargal, R., N. Avidan, E. Ben-Asher, Z. Olender, M. Zeigler, A. Frumkin, A. Raas-Rothschild, G. Glusman, D. Lancet, and G. Bach. 2000. Identification of the gene causing mucolipidosis type IV. Nat. Genet. 26:118-123.
2. Bassi, M.T., M. Manzoni, E. Monti, M.T. Pizzo, A. Ballabio, and G. Borsani. 2000. Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV. Am. J. Hum. Genet. 67:1110-1120.
3. Slaugenhaupt, S.A., J.S. Acierno Jr., L.A. Helbling, C. Bove, E. Goldin, G. Bach, R. Schiffmann, and J.F. Gusella. 1999. Mapping of the mucolipidosis type IV gene to chromosome 19p and definition of founder haplotypes. Am. J. Hum. Genet. 65:773-778.
4. Sun, M., E. Goldin, S. Stahl, J.L. Falardeau, J.C. Kennedy, J.S. Acierno Jr., C. Bove, C.R. Kaneski, J. Nagle, M.C. Bromley, et al. 2000. Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. Hum. Mol. Genet. 9:2471-2478.
5. Bach, G. 2001. Mucolipidosis type IV. Mol. Genet. Metab. 73:197-203.
6. Schiffmann, R., N.K. Dwyer, I.A. Lubensky, M. Tsokos, V.E. Sutliff, J.S. Latimer, K.P. Frei, R.O. Brady, N.W. Barton, E.J. Blanchette-Mackie, and E. Goldin. 1998. Constitutive achlorhydria in mucolipidosis type IV. Proc. Natl. Acad. Sci. USA. 95:1207-1212.
7. Slaugenhaupt, S.A. 2002. The molecular basis of mucolipidosis type IV. Curr. Mol. Med. 2:445-450.
8. Zeevi, D.A., A. Frumkin, and G. Bach. 2007. TRPML and lysosomal function. Biochim. Biophys. Acta. 1772:851-858.
9. Bargal, R., H.H. Goebel, E. Latta, and G. Bach. 2002. Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin. Neuropediatrics. 33:199-202.
10. Lubensky, I.A., R. Schiffmann, E. Goldin, and M. Tsokos. 1999. Lysosomal inclusions in gastric parietal cells in mucolipidosis type IV: a novel cause of achlorhydria and hypergastrinemia. Am. J. Surg. Pathol. 23:1527-1531.
11. Bargal, R., and G. Bach. 1989. Phosphatidylcholine storage in mucolipidosis IV. Clin. Chim. Acta. 181:167-174.
12. Bargal, R., and G. Bach. 1997. Mucolipidosis type IV: abnormal transport of lipids to lysosomes. J. Inherit. Metab. Dis. 20:625-632.
13. Soyombo, A.A., S. Tjon-Kon-Sang, Y. Rbaibi, E. Bashllari, J. Bisceglia, S. Muallem, and K. Kiselyov. 2006. TRP-ML1 regulates lysosomal pH and acidic lysosomal lipid hydrolytic activity. J. Biol. Chem. 281:7294-7301.
14. Raghavan, S., E. Leshinsky, and E.H. Kolodny. 1999. G(M2)-ganglioside metabolism in situ in mucolipidosis IV fibroblasts. Neurochem. Res. 24:475-479.
15. Bach, G., M. Zeigler, T. Schaap, and G. Kohn. 1979. Mucolipidosis type IV: ganglioside sialidase deficiency. Biochem. Biophys. Res. Commun. 90:1341-1347.
16. Lieser, M., E. Harms, H. Kern, G. Bach, and M. Cantz. 1989. Ganglioside GM3 sialidase activity in fibroblasts of normal individuals and of patients with sialidosis and mucolipidosis IV. Subcellular distribution and some properties. Biochem. J. 260:69-74.
17. Bargal, R., and G. Bach. 1988. Phospholipids accumulation in mucolipidosis IV cultured fibroblasts. J. Inherit. Metab. Dis. 11:144-150.
18. Jansen, S.M., J.E. Groener, W. Bax, and B.J. Poorthuis. 2001. Delayed lysosomal metabolism of lipids in mucolipidosis type IV fibroblasts after LDL-receptor-mediated endocytosis. J. Inherit. Metab. Dis. 24:577-586.
19. Kiselyov, K., J. Chen, Y. Rbaibi, D. Oberdick, S. Tjon-Kon-Sang, N. Shcheynikov, S. Muallem, and A. Soyombo. 2005. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J. Biol. Chem. 280:43218-43223.
20. Miedel, M.T., K.M. Weixel, J.R. Bruns, L.M. Traub, and O.A. Weisz. 2006. Posttranslational cleavage and adaptor protein complex-dependent trafficking of mucolipin-1. J. Biol. Chem. 281:12751-12759.
21. Pryor, P.R., F. Reimann, F.M. Gribble, and J.P. Luzio. 2006. Mucolipin-1 is a lysosomal membrane protein required for intracellular lactosylceramide traffic. Traffic. 7:1388-1398.
22. Vergarajauregui, S., and R. Puertollano. 2006. Two di-leucine motifs regulate trafficking of mucolipin-1 to lysosomes. Traffic. 7:337-353.
23. Chen, C.S., G. Bach, and R.E. Pagano. 1998. Abnormal transport along the lysosomal pathway in mucolipidosis, type IV disease. Proc. Natl. Acad. Sci. USA. 95:6373-6378.
24. LaPlante, J.M., J. Falardeau, M. Sun, M. Kanazirska, E.M. Brown, S.A. Slaugenhaupt, and P.M. Vassilev. 2002. Identification and characterization of the single channel function of human mucolipin-1 implicated in mucolipidosis type IV, a disorder affecting the lysosomal pathway. FEBS Lett. 532:183-187.
25. Raychowdhury, M.K., S. Gonzalez-Perrett, N. Montalbetti, G.A. Timpanaro, B. Chasan, W.H. Goldmann, S. Stahl, A. Cooney, E. Goldin, and H.F. Cantiello. 2004. Molecular pathophysiology of mucolipidosis type IV: pH dysregulation of the mucolipin-1 cation channel. Hum. Mol. Genet. 13:617-627.
26. Cantiello, H.F., N. Montalbetti, W.H. Goldmann, M.K. Raychowdhury, S. Gonzalez-Perrett, G.A. Timpanaro, and B. Chasan. 2005. Cation channel activity of mucolipin-1: the effect of calcium. Pflugers Arch. 451:304-312.
27. Xu, H., M. Delling, L. Li, X. Dong, and D.E. Clapham. 2007. Activating mutation in a mucolipin transient receptor potential channel leads to melanocyte loss in varitint-waddler mice. Proc. Natl. Acad. Sci. USA. 104:18321-18326.
28. LaPlante, J.M., C.P. Ye, S.J. Quinn, E. Goldin, E.M. Brown, S.A. Slaugenhaupt, and P.M. Vassilev. 2004. Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV. Biochem. Biophys. Res. Commun. 322:1384-1391.
29. Luzio, J.P., V. Poupon, M.R. Lindsay, B.M. Mullock, R.C. Piper, and P.R. Pryor. 2003. Membrane dynamics and the biogenesis of lysosomes. Mol. Membr. Biol. 20:141-154.
30. Luzio, J.P., P.R. Pryor, and N.A. Bright. 2007. Lysosomes: fusion and function. Nat. Rev. Mol. Cell Biol. 8:622-632.
31. Piper, R.C., and J.P. Luzio. 2004. CUPpling calcium to lysosomal biogenesis. Trends Cell Biol. 14:471-473.
32. Pryor, P.R., B.M. Mullock, N.A. Bright, S.R. Gray, and J.P. Luzio. 2000. The role of intraorganellar Ca2 + in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 149:1053-1062.
33. Treusch, S., S. Knuth, S.A. Slaugenhaupt, E. Goldin, B.D. Grant, and H. Fares. 2004. Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis. Proc. Natl. Acad. Sci. USA. 101:4483-4488.
34. Schaheen, L., H. Dang, and H. Fares. 2006. Basis of lethality in C. elegans lacking CUP-5, the Mucolipidosis Type IV orthologue. Dev. Biol. 293:382-391.
35. Fares, H., and I. Greenwald. 2001. Genetic analysis of endocytosis in Caenorhabditis elegans: coelomocyte uptake defective mutants. Genetics. 159:133-145.
36. Fares, H., and I. Greenwald. 2001. Regulation of endocytosis by CUP-5, the Caenorhabditis elegans mucolipin-1 homolog. Nat. Genet. 28:64-68.
37. Jentsch, T.J., M. Poet, J.C. Fuhrmann, and A.A. Zdebik. 2005. Physiological functions of CLC Cl - channels gleaned from human genetic disease and mouse models. Annu. Rev. Physiol. 67:779-807.
38. Pagano, R.E. 2003. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 358:885-891.
39. Bach, G., C.S. Chen, and R.E. Pagano. 1999. Elevated lysosomal pH in Mucolipidosis type IV cells. Clin. Chim. Acta. 280:173-179.
40. Kopitz, J., C. Gerhard, P. Hofler, and M. Cantz. 1994. [14C]Methylamine accumulation in cultured human skin fibroblasts-a biochemical test for lysosomal storage and lysosomal diseases. Clin. Chim. Acta. 227:121-133.
41. Goldin, E., E.J. Blanchette-Mackie, N.K. Dwyer, P.G. Pentchev, and R.O. Brady. 1995. Cultured skin fibroblasts derived from patients with mucolipidosis 4 are auto-fluorescent. Pediatr. Res. 37:687-692.
42. Belhoussine, R., H. Morjani, S. Sharonov, D. Ploton, and M. Manfait. 1999. Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes. Int. J. Cancer. 81:81-89.
43. Thompson, E.G., L. Schaheen, H. Dang, and H. Fares. 2007. Lysosomal trafficking functions of mucolipin-1 in murine macrophages. BMC Cell Biol. 8:54.
44. Groener, J.E., W. Bax, and B.J. Poorthuis. 1996. Metabolic fate of oleic acid derived from lysosomal degradation of cholesteryl oleate in human fibroblasts. J. Lipid Res. 37:2271-2279.
45. Maxfield, F.R., and T.E. McGraw. 2004. Endocytic recycling. Nat. Rev. Mol. Cell Biol. 5:121-132.
46. Mukherjee, S., R.N. Ghosh, and F.R. Maxfield. 1997. Endocytosis. Physiol. Rev. 77:759-803.
47. Weisz, O.A. 2003. Acidification and protein traffic. Int. Rev. Cytol. 226:259-319.
48. Ikonen, E. 2006. Mechanisms for cellular cholesterol transport: defects and human disease. Physiol. Rev. 86:1237-1261.
49. Maxfield, F.R., and I. Tabas. 2005. Role of cholesterol and lipid organization in disease. Nature. 438:612-621.
50. Di, A., M.E. Brown, L.V. Deriy, C. Li, F.L. Szeto, Y. Chen, P. Huang, J. Tong, A.P. Naren, V. Bindokas, et al. 2006. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat. Cell Biol. 8:933-944.
51. Holopainen, J.M., J. Saarikoski, P.K. Kinnunen, and I. Jarvela. 2001. Elevated lysosomal pH in neuronal ceroid lipofuscinoses (NCLs). Eur. J. Biochem. 268:5851-5856.
52. Jennings, J.J., Jr., J.H. Zhu, Y. Rbaibi, X. Luo, C.T. Chu, and K. Kiselyov. 2006. Mitochondrial aberrations in mucolipidosis Type IV. J. Biol. Chem. 281:39041-39050.
53. Terpstra, A.H., R.J. Nicolosi, and P.N. Herbert. 1989. In vitro incorporation of radiolabeled cholesteryl esters into high and low density lipoproteins. J. Lipid Res. 30:1663-1671.
54. Brown, M.S., S.E. Dana, and J.L. Goldstein. 1975. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc. Natl. Acad. Sci. USA. 72:2925-2929